Amicus Therapeutics Inc (MEX:FOLD)
MXN 208.8 0 (0%) Market Cap: 60.68 Bil Enterprise Value: 64.66 Bil PE Ratio: 0 PB Ratio: 16.63 GF Score: 78/100

Amicus Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2021 / 01:20PM GMT
Release Date Price: MXN430.75
Anupam Rama
JPMorgan Chase & Co, Research Division - VP and Analyst

Welcome, everyone, to the 39th Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Tessa Romero and Matt Bannon from the team.

Our next presenting company is Amicus and presenting on behalf of the company, we have, CEO, John Crowley. Before I turn it over to John, (Operator Instructions)

With that, I'll pass it over to you, John.

John F. Crowley
Amicus Therapeutics, Inc. - Chairman & CEO

Great. Good morning, Anupam. Good morning, everybody. Thank you, JPMorgan, for hosting. I will mention that I'll be making forward-looking statements, and we'll refer you to our forward-looking statements section on Slide 2.

Let me begin though on Slide 3, and this is really the foundation of Amicus. Again, what we've been striving to achieve over the last several years and now looking out to the future is to build a great biotechnology company. And this slide on 3 here really shows you the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot